Prediction of Hypothyroidism after Partial Thyroidectomy for Thyrotoxicosis
W. MICHIE, C. A. S. PEGG, P. D. BEWSHER British Medical Journal, 1972, 1, 13-17 Summary Hypothyroidism is one of the major complications after thyroidectomy for thyrotoxicosis, but the factors responsible are not well defined. In an attempt to define these factors 278 patients operated on in 1965-9 were studied in detail. The overall incidence ofhypothyroidism was 49%. The high incidence of hypothyroidism during 1965-6 led to a policy of leaving larger remnants in, the later years of the study, and it became apparent that the most important aetiological factor in postoperative hypothyroidism was small remnant size. There seemed to be an association between the incidence of hypothyroidism and the presence of antithyroglobulin antibodies, but this association was not statistically significant. The data suggested that blood group 0 might be more common and blood group A less common in hypothyroid patients. The incidence of hypothyroidism seemed to be uninfluenced by the age or sex of the patient, the size of the gland, or the amount and duration of preoperative antithyroid drug therapy. Though a reasonable prediction of the incidence of hypothyroidism can be made for a group of patients on the basis of remnant size, the fate of the individual can be predicted only within very wide limits. An indication of the future status of the individual patient at one year and subsequently does, however, seem possible from serum protein-bound iodine estimations at one and four months after operation. Hypothyroidism developing later than one year after operation has not been observed in this series. The ability to assess thyroid status early after surgery is of some merit in the long-term supervision of the postoperative thyrotoxic patient, and in this respect surgical treatment seems to have some advantage over radioiodine therapy.
Introduction
The plurality of treatment of the thyrotoxic patient is an indication that none of the methods available is wholly acceptable. Hypothyroidism constitutes the major complication. After radioiodine therapy it is consequent on the biological effect of ionizing radiation on the replicative mehanism of the thyroid follicular cell (Greig, 1965 ). An incidence of 70% hypothyroidism 10 years after 131I therapy has been estimated (Nofal et al., 1966) , and since the process of interference with cell reproduction is a continuing one it is possible that nearly all patients treated by radioiodine may eventually become hypothyroid. The reported incidence of hypothyroidism after partial thyroidectomy ranges from 3-5 to 35% in this country (Riddell, 1962; Hedley et al., 1970a) and [4] [5] to 48% inthe United States (Cattell, 1949; Beahrs and Sakulsky, 1968) , but the higher figures may merely represent more critical evaluation of postoperative thyroid status.
Though the behaviour of a group of patients after surgery is known, the metabolic future of the individual patient is unpredictable. In this paper we seek to examine some factors, both for the group and in the individual patient, which might influence the development of hypothyroidism after surgery and be of value in its early diagnosis and subsequent management: (1) in preoperative assessment and preparation, (2) surgical considerations, and (3) in early postoperative behaviour.
Patients and Methods
We have studied 278 patients (235 female and 43 male) treated by partial thyroidectomy for primary thyrotoxicosis and toxic nodular goitre during 1965-9 inclusive. The diagnosis was based on the clinical diagnostic index of Crooks et al. (1959) and serum protein-bound iodine (P.B.127I) estimations (normal range for our laboratory 4-8 ,ug/100 ml), and confirmed by a radioactive tracer test supplemented where necessary by the response to triiodothyronine (Hobbs et al., 1963) . Hypothyroidism was assessed by clinical examination based on the standard diagnostic index described by Billewicz et al. (1969) , on electrocardiographic evidence, and on serial serum P.B.1271 and cholesterol estimations. The final arbiter was a therapeutic trial with thyroxine (Werner and Spooner, 1955) . Patients were examined at one, four, and twelve months after operation and thereafter on a yearly basis until the services of a computer-assisted register became available (Hedley et al., 1970b Age.-The ages of the patients varied from 16 to 65 years. The incidence of hypothyroidism shows no trend with age of the patient at the time of operation (Table I ) and though 71% of the patients of 61 years or more became hypothyroid, the numbers are too small to be meaningful. Blood Group.-Records are available for 123 patients; in these the incidence of 0 and A blood groups is identical with the general population in the north-east of Scotland (Mourant et al., 1958) (Table II) . Group 0 was slightly more common in hypothyroid (P<0 1) than in euthyroid patients and group A less common (P=0 05) (Table III) . Antithyroid Drugs.-The choice of antithyroid drugs and the duration of therapy were determined by the individual physicians who supervised the preoperative care of the patients. Both carbimazole and methylthiouracil were used, the former in 205 patients and the latter in 67. Six received both drugs at different times. To effect a crude comparison carbimazole wasregardedasbeing 10times more potent than methylthiouracil, and the prescribed doses of both drugs are given in terms of carbimazole. Though a record of the prescribed dose was kept, no attempt was made to verify that the patient had always taken the recommended dose. Neither the amount of antithyroid drugs prescribed nor the duration of therapy affected the incidence of hypothyroidism (Tables IV and V) .
Antithyroid Antibody Tests.-Details of antithyroid antibody tests carried out preoperatively are available for 191 patients. Results of both tests were graded as negative, positive, and strongly positive (Table VI) . Antithyroglobulin (tanned red cell) antibody (positive and strongly positive) was more prevalent in hypothyroid than in euthyroid patients, though this difference is not statistically significant (P <0-1). Before operation 33 (17%) of 191 patients had a positive tanned red cell But even with this variation it can be seen that the incidence of hypothyroidism decreased significantly as remnant size increased (P<0001) ( Table VII) .
Total gland mass was calculated from the estimated remnant weight plus the weight of the resected thyroid specimen. Six glands were less than 20 g, and 33 were 100 g or more.
The average gland mass for hypothyroid patients was 55 g, for euthyroid patients 60 g, and for the series as a whole 57 g. The incidence of hypothyroidism in relation to total gland mass is shown in Table VIII . Since remnant size has a pronounced effect on the incidence of hypothyroidism, we have examiined the data for total gland mass, controlled for remnant weight (Fig. 1) . It can be seen that for any given remnant weight the total gland mass does not differ between euthyroid and hypothyroid patients. Fig. 2 shows that, for the same gland weight, the thyroid remnant was consistently smaller for patients who became hypothyroid. Fig. 1 also shows that remnant size tended to increase with increasing total gland weight. The increase, however, was only slight (about 60%) for a fivefold increase in gland weight.
As indicated earlier the high hypothyroid rate found during 1965-6 dictated a policy of leaving larger remnants. This led to a reduction in the incidence of hypothyroidism (P <0 02) during the last three years of the study (Table IX) . While the incidence of hypothyroidism in a series of patients is closely associated with remnant size, and possibly with positive antithyroglobulin antibodies and with blood group 0, it is quite impossible to predict the future of the individual patient. Hypothyroidism can occur when a generous remnant of 10 to 12 g has been left, thyrotoxic recurrence with a remnant as small as 4 g. This unpredictable response constitutes a problem in postoperative management. The records of the Research and Intelligence Unit of the Scottish Home and Health Department show that on average 350 thyrotoxic patients came to thyroidectomy annually in Scotland during the years 1965-9 compared with an average of 450 patients treated each year by radioiodine. Thus about 800 patients are subjected to destructive therapy in Scotland each year.
The numbers are such that it becomes difficult to supervise adequately all these patients in routine follow-up clinics. It is for this reason that a computer-assisted register has been developed (Hedley et al., 1970b) , but it will be several years before this service will become generally available.
Data for 3 patients incomplete.
(7%) were on replacement therapy at one year and subsequently. This apparent improvement within the first year might suggest that of the 170 patients with low P.B.127I levels at one and four months postoperatively, a greater proportion than 25% might have become euthyroid at one year if replacement therapy had been withheld. Twenty-one patients operated on during 1965-6, whose P.B.127I values were less than 4 tig/100 ml at one, four, and at twelve months after operation, were kept under observation for a further year. None showed clinical improvement and replacement therapy was started at two years. In the light of this experience we would emphasize that in none of the 128 patients with low P.B.1271 levels at one and four months after operation who were given thyroxine was it considered justifiable to withhold replacement therapy.
Discussion
Review of the results shows that the most significant aetiological factor in postoperative hypothyroidism is small remnant size.
Not only does the association between small remnant size and hypothyroidism hold for the series as a whole but it is also seen in the annual incidence of hypothyroidism during the individual years from 1965 to 1969 when the policy of increasing the remnant size is taken into account. But large remnant size per se will not necessarily abolish hypothyroidism; for patients with a remnant size in the range of 8 to 10 g the hypothyroid rate was 30% (Table VII) .
The larger remnant also introduces the possible hazard of thyrotoxic recurrence. Crile and McCullagh (1951) , Painter. (1960) , and Wilson (1967) observed that the incidence of hypothyroidism is inversely, and of recurrent hyperthyroidism directly, related to remnant size. To date in this series there have been four recurrences in patients whose estimated remnants were 4, 6, 9, and 12 g. Since thyrotoxic recurrence may be diagnosed up to 20 years after operation (Hedley et al., 1970a) , it is possible that others will revert to hyperthyroidism, particularly where large remnants were left at operation.
While the distribution of blood groups in the surgically treated thyrotoxic patients is the same as in the general population in this area, there is a deficit of blood group A in the hypothyroid patients and there seemed to be an excess of blood group 0. The interpretation of this association is as yet obscure.
Similarly patients with positive antithyroglobuilin (tanned red cell) antibody titres seem to be more liable to develop hypothyroidism, but the association is not sufficiently definite to influence management. Though preoperative antithyroid drug therapy in this series was not standardized, it is clear that the incidence of hypothyroidism does not depend on the duration of therapy nor on the amount of drug prescribed.
CONTINUING SUPERVISION
For the present, continuing outpatient supervision is necessary if the not inconsiderable morbidity of hypothyroidism which follows destructive therapy is to be prevented. In this context patients treated surgically may be at an advantage over those receiving radioiodine therapy. The results published to date indicate that after radioiodine therapy the curve of incidence of hypothyroidism shows no tendency to level out. It is possible that most, if not all, patients may be found to develop hypothyroidism if they are followed for a sufficient length of time. In contrast we have good reason to believe that in surgically treated patients the probability of requiring thyroxine replacement therapy may be defined within one year of operation. Furthermore, it has been our experience that if a sufficiently high degree of suspicion of hypothyroidism is maintained during the early postoperative months the late diagnosis of hypothyroidism is rare. Olsen et al. (1970) , using slightly different criteria, found an incidence of hypothyroidism of 23% after 10 years. Of their patients who became hypothyroid, 88% were diagnosed within six months of operation and 96% within two years; they considered that the risk of developing hypothyroidism after two years was 1%. On the other hand, Nofal et al. (1966) found a postoperative hypothyroid incidence of 22% after six months rising to 25% at the end of a year, with a yearly increase thereafter of 1-7% for up to 10 years.
The incidence of hypothyroidism in this series is high (49%) but it is apparent that the incidence of hypothyroidism is influenced by remnant size. Provided a remnant of 8 to 9 g is left it is possible to offer a group prediction of 70% euthyroidism (Table VII) but it is not possible to predict the fate of the individual patient from remnant size alone. In contrast P.B.127I estimations alone are of prognostic value for both the group and the individual. Where P.B.127I values at one and four months after operation are 4 [Lg/100 ml or more it may be assumed with reasonable confidence that these patients will remain euthyroid. Where both P.B.127I values are less than 4 ,ug/100 ml the risk of requiring thyroxine replacement is 75%. Thus within one year it may be possible to define the ultimate thyroid status of the individual patient and to establish whether thyroxine replacement therapy will be necessary in the future. This is a matter of importance for the busy surgeon for whom a computer-assisted register may not become available for several years. Provided an adequate remnant of 8 to 9 g is left he can assume that some 70% of his patients will be euthyroid. Though in ideal circumstances all thyrotoxic patients subjected to surgery merit life-long supervision, special attention should be given to those whose early postoperative P.B.127I levels have been less than 4 psg/100 ml.
They are known to inhibit a number of enzyme systems. Often it is assumed that inhibition of monoamine oxidase is the most likely way in which they affect mental depression, but this is by no means certain. Recently their action as M.A.O.I.s has been complicated by the discovery of multiple forms of this enzyme (Youdim et al., 1969; Collins et al., 1970) in human brain mitochondria, each with a characteristic anatomical distribution and each with its own substrate specificity and sensitivity to inhibitors (Johnson, 1968; Fuller et al., 1970) .
In 1965 we showed that it is possible to assess the effect of M.A.O.I.s on the concentration of 5-hydroxytryptamine (5HT) in human brain (Maclean et al., 1965) . We have now extended this work to investigate the effect of three M.A.O.I.s on the concentrations in human brain of 5HT, noradrenaline, and dopamine. The inhibitors used were: isocarboxazid, a typical hydrazide inhibitor; tranylcypromine, a non-hydrazide with amphetamine-like actions; and clorgyline, a non-hydrazide which is reported to have a pronounced difference in its potency against two of the monoamine oxidase isoenzymes (Johnson, 1968; Hall et al., 1969 
